ProMIS Neurosciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
PMN Nasdaq 2834 www.promisneurosciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ProMIS Neurosciences, Inc.

ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September - Sep 1st, 2026 6:00 am
ProMIS Neurosciences Inc (PMN) (Q2 2026) Earnings Call Highlights: Zero ARIA-E Cases and ... - Aug 13th, 2026 11:02 pm
Promis Neurosciences Q2 Earnings Call Highlights - Aug 13th, 2026 8:04 pm
ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights - Aug 13th, 2026 2:00 pm
ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Aug 3rd, 2026 2:00 pm
Promis Reports No ARIA-E in PMN310 Alzheimer’s Trial Interim Data - Jul 28th, 2026 12:04 pm
ProMIS Neurosciences Shares Climb on Positive Interim Alzheimer’s Trial Safety Results - Jul 28th, 2026 6:25 am
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial - Jul 28th, 2026 4:00 am
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease - Jul 27th, 2026 2:00 pm
Can Acute Care Strength Offset Universal Health's Rising Q2 Costs? - Jul 23rd, 2026 10:44 am
Will Lower Patient Days Affect Tenet Healthcare's Q2 Earnings? - Jul 21st, 2026 9:44 am
Will Higher Expenses Impact HCA Healthcare's Q2 Earnings? - Jul 20th, 2026 10:13 am
Will Declining Membership Affect Molina Healthcare's Q2 Earnings? - Jul 17th, 2026 8:44 am
ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026 - Jul 14th, 2026 12:30 am
Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move This High? - Jun 30th, 2026 7:55 am
All You Need to Know About Promis Neurosciences (PMN) Rating Upgrade to Buy - Jun 12th, 2026 10:00 am
Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet - Jun 12th, 2026 7:55 am
ProMIS Neurosciences to Participate in Upcoming Conferences in June - May 28th, 2026 8:13 am
ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights - May 12th, 2026 4:30 am
ProMIS Neurosciences Invited to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference - Apr 13th, 2026 5:30 am